Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma and periostin expression

Cancer Letters

Volumn 281, Issue 2, 2009, Pages 188-195

  Bai, Yanhua ^a,b   Kakudo, Kennichi ^b   Nakamura, Misa ^b,c   Ozaki, Takashi ^b   Li, Yaqiong ^a,b   Liu, Zhiyan ^a,b   Mori, Ichiro ^b   Miyauchi, Akira ^d   Zhou, Gengyin ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c OSAKA KAWASAKI REHABILITATION UNIVERSITY   (Japan)

^d KUMA HOSPITAL   (Japan)

Author keywords

Cohesiveness; Epithelial mesenchymal transition; Periostin; Polarity; Thyroid carcinoma

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR RUNX2;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CELL ADHESION; CELL POLARITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID PAPILLARY CARCINOMA; TISSUE SECTION; UPREGULATION;

ADENOCARCINOMA, PAPILLARY; ADULT; AGED; CELL ADHESION MOLECULES; CELL POLARITY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 67349084977     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.02.043     Document Type: Article

References (32)

1. Bai Y., Kakudo K., Li Y., Liu Z., Ozaki T., Ito Y., Kihara M., and Miyauchi A. Subclassification of non-solid-type papillary thyroid carcinoma identification of high-risk group in common type. Cancer Sci. 99 (2008) 1908-1915
2. Akslen L.A., Myking A.O., Salvesen H., and Varhaug J.E. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur. J. Cancer 29A (1992) 44-51
3. Noguchi S., Murakami N., and Kawamoto H. Classification of papillary cancer of the thyroid based on prognosis. World J. Surg. 18 (1994) 552-557 discussion 558
4. Kudo Y., Siriwardena B.S., Hatano H., Ogawa I., and Takata T. Periostin: novel diagnostic and therapeutic target for cancer. Histol. Histopathol. 22 (2007) 1167-1174
5. Shao R., Bao S., Bai X., Blanchette C., Anderson R.M., Dang T., Gishizky M.L., Marks J.R., and Wang X.F. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol. Cell. Biol. 24 (2004) 3992-4003
6. Sasaki H., Dai M., Auclair D., Fukai I., Kiriyama M., Yamakawa Y., Fujii Y., and Chen L.B. Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 92 (2001) 843-848
7. Erkan M., Kleeff J., Gorbachevski A., Reiser C., Mitkus T., Esposito I., Giese T., Buchler M.W., Giese N.A., and Friess H. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 132 (2007) 1447-1464
8. Siriwardena B.S., Kudo Y., Ogawa I., Kitagawa M., Kitajima S., Hatano H., Tilakaratne W.M., Miyauchi M., and Takata T. Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br. J. Cancer 95 (2006) 1396-1403
9. Kudo Y., Ogawa I., Kitajima S., Kitagawa M., Kawai H., Gaffney P.M., Miyauchi M., and Takata T. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res. 66 (2006) 6928-6935
10. Bao S., Ouyang G., Bai X., Huang Z., Ma C., Liu M., Shao R., Anderson R.M., Rich J.N., and Wang X.F. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5 (2004) 329-339
11. Gillan L., Matei D., Fishman D.A., Gerbin C.S., Karlan B.Y., and Chang D.D. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res. 62 (2002) 5358-5364
12. Puppin C., Fabbro D., Dima M., Di Loreto C., Puxeddu E., Filetti S., Russo D., and Damante G. High periostin expression correlates with aggressiveness in papillary thyroid carcinomas. J. Endocrinol. 197 (2008) 401-408
13. Yan W., and Shao R. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J. Biol. Chem. 281 (2006) 19700-19708
14. Higashikawa K., Yoneda S., Taki M., Shigeishi H., Ono S., Tobiume K., and Kamata N. Gene expression profiling to identify genes associated with high-invasiveness in human squamous cell carcinoma with epithelial-to-mesenchymal transition. Cancer Lett. 264 (2008) 256-264
15. Janda E., Lehmann K., Killisch I., Jechlinger M., Herzig M., Downward J., Beug H., and Grunert S. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156 (2002) 299-313
16. Vasko V., Espinosa A.V., Scouten W., He H., Auer H., Liyanarachchi S., Larin A., Savchenko V., Francis G.L., de la Chapelle A., Saji M., and Ringel M.D. Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc. Natl. Acad. Sci. USA 104 (2007) 2803-2808
17. Kudo Y., Kitajima S., Ogawa I., Hiraoka M., Sargolzaei S., Keikhaee M.R., Sato S., Miyauchi M., and Takata T. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin. Cancer Res. 10 (2004) 5455-5463
18. Nakajima S., Doi R., Toyoda E., Tsuji S., Wada M., Koizumi M., Tulachan S.S., Ito D., Kami K., Mori T., Kawaguchi Y., Fujimoto K., Hosotani R., and Imamura M. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin. Cancer Res. 10 (2004) 4125-4133
19. Kakudo K., Tang W., Ito Y., Mori I., Nakamura Y., and Miyauchi A. Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J. Clin. Pathol. 57 (2004) 1041-1046
20. Tang W., Nakamura Y., Zuo H., Yasuoka H., Yang Q., Wang X., Nakamura M., Mori I., Miyauchi A., and Kakudo K. Differentiation, proliferation and retinoid receptor status of papillary carcinoma of the thyroid. Pathol. Int. 53 (2003) 204-213
21. Fluge O., Bruland O., Akslen L.A., Lillehaug J.R., and Varhaug J.E. Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid 16 (2006) 161-175
22. Wang X., Nakamura M., Mori I., Takeda K., Nakamura Y., Utsunomiya H., Yoshimura G., Sakurai T., and Kakudo K. Calcitonin receptor gene and breast cancer: quantitative analysis with laser capture microdissection. Breast Cancer Res. Treat. 83 (2004) 109-117
23. Lehmann U., Langer F., Feist H., Glockner S., Hasemeier B., and Kreipe H. Quantitative assessment of promoter hypermethylation during breast cancer development. Am. J. Pathol. 160 (2002) 605-612
24. Kinnman N., Francoz C., Barbu V., Wendum D., Rey C., Hultcrantz R., Poupon R., and Housset C. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab. Invest. 83 (2003) 163-173
25. Xu L.L., Stackhouse B.G., Florence K., Zhang W., Shanmugam N., Sesterhenn I.A., Zou Z., Srikantan V., Augustus M., Roschke V., Carter K., McLeod D.G., Moul J.W., Soppett D., and Srivastava S. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor is overexpressed in prostate cancer. Cancer Res. 60 (2000) 6568-6572
26. Takeshita S., Kikuno R., Tezuka K., and Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J. 294 Pt 1 (1993) 271-278
27. Zinn K., McAllister L., and Goodman C.S. Sequence analysis and neuronal expression of fasciclin I in grasshopper and drosophila. Cell 53 (1988) 577-587
28. Wang W.C., Zinn K., and Bjorkman P.J. Expression structural studies of fasciclin I an insect cell adhesion molecule. J. Biol. Chem. 268 (1993) 1448-1455
29. Skonier J., Neubauer M., Madisen L., Bennett K., Plowman G.D., and Purchio A.F. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol. 11 (1992) 511-522
30. Horiuchi K., Amizuka N., Takeshita S., Takamatsu H., Katsuura M., Ozawa H., Toyama Y., Bonewald L.F., and Kudo A. Identification and characterization of a novel protein periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 14 (1999) 1239-1249
31. Litvin J., Selim A.H., Montgomery M.O., Lehmann K., Rico M.C., Devlin H., Bednarik D.P., and Safadi F.F. Expression and function of periostin-isoforms in bone. J. Cell Biochem. 92 (2004) 1044-1061
32. Tai I.T., Dai M., and Chen L.B. Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. Carcinogenesis 26 (2005) 908-915